GENEVA, Oct. 1 -- ZENO THERAPEUTICS PTE. LTD. filed a patent application (EP2026/056589) for “SURFACE SRRM2 AS BIOMARKER OF PROGNOSIS AND MOLECULAR TARGET FOR IMMUNOTHERAPY OF AML”. With publication no. WO/2026/190091, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: G01N 33/57505
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....